Jeffrey S. Parkin

Array ( [id] => 7662300 [patent_doc_number] => 20110311569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/309256 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13279 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311569.pdf [firstpage_image] =>[orig_patent_app_number] => 12309256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771417 [patent_doc_number] => 20080057075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of inducing neutralizing antibodies to human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/812992 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9657 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057075.pdf [firstpage_image] =>[orig_patent_app_number] => 11812992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583722 [patent_doc_number] => 20100047765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MOLECULAR DETERMINANTS ASSOCIATED WITH ENHANCED ABILITY TO ENTER CELLS EXPRESSING CXCR4' [patent_app_type] => utility [patent_app_number] => 12/304418 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047765.pdf [firstpage_image] =>[orig_patent_app_number] => 12304418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463855 [patent_doc_number] => 09580473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/303985 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 14604 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231340 [patent_doc_number] => 20070293448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'SYNTHETIC GAGPOL GENES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 11/754755 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15182 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293448.pdf [firstpage_image] =>[orig_patent_app_number] => 11754755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322957 [patent_doc_number] => 20090060947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Immunological compositions' [patent_app_type] => utility [patent_app_number] => 11/804601 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12126 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060947.pdf [firstpage_image] =>[orig_patent_app_number] => 11804601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872760 [patent_doc_number] => 20080199494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 11/748229 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3673 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199494.pdf [firstpage_image] =>[orig_patent_app_number] => 11748229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651460 [patent_doc_number] => 20080038716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/746404 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17468 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038716.pdf [firstpage_image] =>[orig_patent_app_number] => 11746404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687709 [patent_doc_number] => 20080031890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Method of inducing neutralizing antibodies to human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/785077 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031890.pdf [firstpage_image] =>[orig_patent_app_number] => 11785077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658126 [patent_doc_number] => 20080026988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Compositions and methods for human immunodeficiency virus vaccination' [patent_app_type] => utility [patent_app_number] => 11/786855 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31703 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026988.pdf [firstpage_image] =>[orig_patent_app_number] => 11786855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860612 [patent_doc_number] => 20080269462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Peptide inhibitors of HIV entry' [patent_app_type] => utility [patent_app_number] => 11/786764 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9389 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269462.pdf [firstpage_image] =>[orig_patent_app_number] => 11786764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435169 [patent_doc_number] => 08282937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Cold-adapted (CA) reassortant influenza virus' [patent_app_type] => utility [patent_app_number] => 11/690498 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20137 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11690498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159406 [patent_doc_number] => 20070172450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'MODULATION OF IMMUNE RESPONSE AND METHODS BASED THEREON' [patent_app_type] => utility [patent_app_number] => 11/687952 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13232 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172450.pdf [firstpage_image] =>[orig_patent_app_number] => 11687952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159886 [patent_doc_number] => 20070172930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 11/724551 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 8340 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172930.pdf [firstpage_image] =>[orig_patent_app_number] => 11724551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745306 [patent_doc_number] => 20080089908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/724050 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 158 [patent_figures_cnt] => 158 [patent_no_of_words] => 45580 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11724050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859143 [patent_doc_number] => 20080267993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'AIDS vaccines' [patent_app_type] => utility [patent_app_number] => 11/713124 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12327 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267993.pdf [firstpage_image] =>[orig_patent_app_number] => 11713124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479665 [patent_doc_number] => 20090202622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'VIROSOME-LIKE VESICLES COMPRISING GP41-DERIVED ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/281256 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9524 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202622.pdf [firstpage_image] =>[orig_patent_app_number] => 12281256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657587 [patent_doc_number] => 20080026448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Production of HIV' [patent_app_type] => utility [patent_app_number] => 11/707755 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16876 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026448.pdf [firstpage_image] =>[orig_patent_app_number] => 11707755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068976 [patent_doc_number] => 20070190077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Anti-HIV agents' [patent_app_type] => utility [patent_app_number] => 11/657070 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11867 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190077.pdf [firstpage_image] =>[orig_patent_app_number] => 11657070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259639 [patent_doc_number] => 20070213271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 11/626687 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14128 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213271.pdf [firstpage_image] =>[orig_patent_app_number] => 11626687 [rel_patent_id] =>[rel_patent_doc_number] =>)